SHELBY PERRY: Open Payments
NPI 1083218101 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 14 payments from 8 companies in 2025. Trend: 2023 $159 · 2024 $60 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $210 |
| HEARTFLOW, INC. | 2 | $202 |
| Amgen Inc. | 5 | $86 |
| Kestra Medical Technology Services, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: SAPIEN 3 Ultra RESILIA, FFRct, REPATHA, Assure WCD, ELIQUIS, LEQVIO, CAMZYOS, FARXIGA.
Industry payments across IN — which companies pay providers there.
